鱼藤酮
神经保护
神经退行性变
多巴胺能
帕金森病
陶氏病
星形胶质增生
神经毒性
多巴胺
药理学
医学
苯丁酸酯
神经科学
内科学
内分泌学
化学
生物
线粒体
中枢神经系统
毒性
生物化学
疾病
作者
Masatoshi Inden,Yoshihisa Kitamura,Hiroki Takeuchi,Takashi Yanagida,Kazuyuki Takata,Yuka Kobayashi,Takashi Taniguchi,Kanji Yoshimoto,Masahiko Kaneko,Yasunobu Okuma,Takahiro Taira,Hiroyoshi Ariga,Shun Shimohama
标识
DOI:10.1111/j.1471-4159.2006.04440.x
摘要
Parkinson's disease (PD) is a progressive neurodegenerative disorder that is primarily characterized by the degeneration of dopaminergic neurons in the nigrostriatal pathway. Previous studies have demonstrated that chronic systemic exposure of Lewis rats to rotenone produced many features of PD, and cerebral tauopathy was also detected in the case of severe weight loss. The present study was designed to assess the neurotoxicity of rotenone after daily oral administration for 28 days at several doses in C57BL/6 mice. In addition, we examined the protective effects of 4-phenylbutyrate (4-PBA) on nigral dopamine (DA) neurons in rotenone-treated mice. 4-PBA was injected intraperitoneally daily 30 min before each oral administration of rotenone. Chronic oral administration of rotenone at high doses induced specific nigrostriatal DA neurodegeneration, motor deficits and the up-regulation of alpha-synuclein in the surviving DA neurons. In contrast to the Lewis rat model, cerebral tauopathy was not detected in this mouse model. 4-PBA inhibited rotenone-induced neuronal death and decreased the protein level of alpha-synuclein. These results suggest that this rotenone mouse model may be useful for understanding the mechanism of DA neurodegeneration in PD, and that 4-PBA has a neuroprotective effect in the treatment of PD.
科研通智能强力驱动
Strongly Powered by AbleSci AI